RxDoctor Payments Data

Trang Pham, MD

Urogynecology and Reconstructive Pelvic Surgery · Wichita, KSNPI 1932596681

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,650 of the $3,714 with a category attached, or 71.4%. 13 manufacturers reported payments, led by Intuitive Surgical at 28.5% of the total. Reporting peaked in 2022 at $1,774 and has fallen 94.4% since, to $99 in 2025.

$3,714in general payments, 2019–2025

Across 57 payments — averaging $65.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • Coloplast$744
  • Axonics, Inc.$650
  • Medtronic$626
  • Caldera Medical, Inc$212
  • Coopersurgical, Inc.$100
  • plus $324 from 7 others

What the payments were for

  • Food & beverage$2,65071%
  • Education$1,01627%
  • Gifts$481%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few urogynecology and reconstructive pelvic surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$275,303
Medicare patients
833
Services billed
13,921

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron267$170,096
MyrbetriqMirabegron76$41,652
Estradiol105$7,506
Trospium Chloride ErTrospium Chloride44$4,728
Trospium Chloride70$3,090
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst100$2,218
Tolterodine Tartrate ErTolterodine Tartrate26$1,463
Methenamine Hippurate25$1,247
Solifenacin Succinate40$944
Clobetasol Propionate31$816
Cephalexin158$750
Oxybutynin Chloride ErOxybutynin Chloride45$684
Cefdinir22$265
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim32$135
Oxycodone Hcl25$97

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →